Functional Massage Versus Passive Mobilization After Total Knee Replacement

Functional Recovery in the Acute Phase After Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Two Different Physiotherapy Protocols

This study compares two physiotherapy treatments to help adults recover movement after total knee replacement: functional massage and passive knee mobilization. The main question is whether functional massage helps patients bend their knee further by the time they leave the acute hospital ward.

Forty adults undergoing replacement of one knee or both knees during the same operation will be randomly assigned to one of two groups. One group will receive functional massage according to Olaf Evjenth, and the other will receive passive manual knee mobilization. Both groups will also receive the same standard rehabilitation and pain management.

The assigned treatment will be provided once daily, starting on the first day after surgery and continuing until hospital discharge. Each treatment will last 10 minutes per operated knee.

A clinician who does not know which treatment the patient received will assess knee movement. The study will also evaluate pain, functional mobility, patient-reported outcomes, and length of hospital stay.

Study Overview

Detailed Description

This is a single-center, randomized, parallel-group superiority trial comparing two manual physiotherapy approaches during the acute phase after total knee arthroplasty.

An independent researcher will generate the random allocation sequence. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes, opened after eligibility has been confirmed and written informed consent obtained.

The primary analysis will follow the intention-to-treat principle. Passive knee flexion at discharge will be compared between groups using analysis of covariance, with baseline knee flexion as a covariate. For participants undergoing simultaneous bilateral total knee arthroplasty, one knee will be randomly selected for the primary analysis. A sensitivity analysis using mixed-effects models will account for paired knee measurements. Exploratory analyses will compare treatment effects in participants undergoing unilateral and simultaneous bilateral surgery.

Discharge timing depends on the availability of a bed in an inpatient rehabilitation facility rather than on predefined functional recovery thresholds.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Verona
      • Verona, Verona, Italy, 37126
        • Azienda Ospedaliera Universitaria Integrata Verona - U.O.C. Ortopedia, Ospedale Chirurgico Confortini
        • Contact:
        • Contact:
        • Principal Investigator:
          • Simone Patuzzo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female patients aged 18 to 79 years.
  • Scheduled for elective primary total knee arthroplasty, either unilateral or simultaneous bilateral.
  • Ability to understand the nature of the study and provide written informed consent.

Exclusion Criteria:

  • Revision total knee arthroplasty.
  • Age 80 years or older.
  • Severe comorbidities that could interfere with participation in the rehabilitation protocol or outcome assessment, including severe heart failure, severe chronic obstructive pulmonary disease, severe obesity with body mass index greater than 40 kg/m², or neurological conditions with significant motor deficits.
  • Cognitive deficits that prevent understanding and signing the informed consent or active participation in rehabilitation.
  • Total knee arthroplasty performed for non-degenerative causes, such as acute trauma or tumors.
  • Concomitant participation in another interventional clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Functional Massage

Participants receive functional massage according to Olaf Evjenth once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

Functional massage of the anterior thigh with passive or active-assisted knee flexion, performed with the patient seated. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

Active Comparator: Passive Manual Mobilization

Participants receive passive manual knee mobilization once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

Passive manual knee flexion and extension in the sagittal plane, performed with the patient supine. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Flexion
Time Frame: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Passive knee flexion is measured in degrees using a standard goniometer, with the assessor moving the knee. Measurements are collected daily from postoperative day 1 until hospital discharge

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity
Time Frame: At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Pain intensity is assessed using a Visual Analogue Scale and recorded on a 0-10 scale, with higher scores indicating greater pain. Measurements are collected at baseline and daily after each rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Each daily measurement is recorded separately.

At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
Timed Up and Go Test
Time Frame: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Time in seconds required to stand up, walk 3 meters, turn, walk back, and sit down. The test is performed daily after the rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Shorter times indicate better functional mobility. Each daily measurement is recorded separately.

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
Length of Hospital Stay
Time Frame: At discharge from the acute hospital ward, typically 5-7 days after surgery.

Number of days from admission to the acute hospital ward until discharge

At discharge from the acute hospital ward, typically 5-7 days after surgery.
Oxford Knee Score on Postoperative Day 1
Time Frame: Postoperative day 1.

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

Postoperative day 1.
Oxford Knee Score at Hospital Discharge
Time Frame: At discharge from the acute hospital ward, typically 5-7 days after surgery.

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

At discharge from the acute hospital ward, typically 5-7 days after surgery.
Oxford Knee Score at 1 Month
Time Frame: 1 month after surgery

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

1 month after surgery
Oxford Knee Score at 3 Months
Time Frame: 3 months after surgery

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

3 months after surgery
EQ-5D-5L Utility Index at day 1
Time Frame: Postoperative day 1.

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life

Postoperative day 1.
EQ-5D-5L Utility Index at discharge
Time Frame: At discharge from the acute hospital ward, typically 5-7 days after surgery.

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life.

At discharge from the acute hospital ward, typically 5-7 days after surgery.
EQ-5D-5L Utility Index at 1 Month
Time Frame: 1 month after surgery

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

1 month after surgery
EQ-5D-5L Utility Index at 3 Months
Time Frame: 3 months after surgery

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

3 months after surgery
EQ VAS on Postoperative Day 1
Time Frame: On postoperative day 1.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

On postoperative day 1.
EQ VAS at Hospital Discharge
Time Frame: At hospital discharge, typically 5-7 days after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

At hospital discharge, typically 5-7 days after surgery.
EQ VAS at 1 Month
Time Frame: At 1 month after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.The assessment is administered by telephone

At 1 month after surgery.
EQ VAS at 3 Months
Time Frame: At 3 months after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. The assessment is administered by telephone

At 3 months after surgery.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking Distance During Assisted Ambulation
Time Frame: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Distance walked during assisted ambulation, measured in meters and recorded daily after the rehabilitation session.

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Simone Patuzzo, Azienda Ospedaliera Universitaria Integrata Verona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 24, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

August 1, 2028

Study Registration Dates

First Submitted

November 3, 2026

First Submitted That Met QC Criteria

November 3, 2026

First Posted (Actual)

November 9, 2026

Study Record Updates

Last Update Posted (Actual)

November 9, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • TKA-PATUZZO-2025-01
  • 1000CET (Other Identifier: Comitato Etico Territoriale Area Sud-Ovest Veneto (CET-ASOV))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe